Bionano Genomics, Inc.

BMV:BNGO * Stock Report

Market Cap: Mex$1.1b

Bionano Genomics Past Earnings Performance

Past criteria checks 0/6

Bionano Genomics's earnings have been declining at an average annual rate of -46.5%, while the Life Sciences industry saw earnings growing at 19.7% annually. Revenues have been growing at an average rate of 31.8% per year.

Key information

-46.5%

Earnings growth rate

41.8%

EPS growth rate

Life Sciences Industry Growth12.9%
Revenue growth rate31.8%
Return on equity-274.0%
Net Margin-605.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Bionano Genomics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BMV:BNGO * Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2437-2279050
31 Dec 2336-2329554
30 Sep 2334-22710056
30 Jun 2332-1479755
31 Mar 2330-1409152
31 Dec 2228-1338649
30 Sep 2226-1178144
30 Jun 2223-1067638
31 Mar 2221-926830
31 Dec 2118-725722
30 Sep 2116-614716
30 Jun 2113-514012
31 Mar 2111-413210
31 Dec 209-413010
30 Sep 207-372810
30 Jun 208-332310
31 Mar 209-322310
31 Dec 1910-30209
30 Sep 1911-281810
30 Jun 1911-271710
31 Mar 1912-23169
31 Dec 1812-18149
30 Sep 1811-18139
30 Jun 1811-181310
31 Mar 1810-221411
31 Dec 1710-231412
31 Dec 167-191311

Quality Earnings: BNGO * is currently unprofitable.

Growing Profit Margin: BNGO * is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BNGO * is unprofitable, and losses have increased over the past 5 years at a rate of 46.5% per year.

Accelerating Growth: Unable to compare BNGO *'s earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BNGO * is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-1.7%).


Return on Equity

High ROE: BNGO * has a negative Return on Equity (-274%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.